flumazenil has been researched along with Blood Pressure, Low in 5 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BACKGROUND Olanzapine is an antipsychotic drug and is used in critical care to treat delirium." | 8.12 | Coma, Severe Hypotension, and Pinpoint Pupils After Olanzapine Intoxication in the Intensive Care Unit with Symptom Reversal After Administration of Flumazenil. ( Aiff, H; Guldberg, J; Gustafsson, JM; Pålsson, P, 2022) |
| "BACKGROUND Olanzapine is an antipsychotic drug and is used in critical care to treat delirium." | 4.12 | Coma, Severe Hypotension, and Pinpoint Pupils After Olanzapine Intoxication in the Intensive Care Unit with Symptom Reversal After Administration of Flumazenil. ( Aiff, H; Guldberg, J; Gustafsson, JM; Pålsson, P, 2022) |
| "Remimazolam tosilate (RT) is a novel short-acting GABA (A) receptor agonist that has a rapid recovery from procedural sedation and can be fully reversed by flumazenil." | 3.30 | Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial. ( Huang, J; Liu, M; Luo, W; Miao, C; Sun, M; Wan, J; Xia, L; Xiong, W; Xu, P; Zhang, J; Zhang, X; Zhang, Z; Zhong, J, 2023) |
| "A 27-year-old man, presented with deep coma, bilateral pinpoint unreactive pupils, acute respiratory failure and hypotension, complicated by hypoxic ischemic changes in the central nervous system." | 1.43 | Flubromazolam--A new life-threatening designer benzodiazepine. ( Panieński, P; Sommerfeld, K; Teżyk, A; Żaba, C; Zielińska-Psuja, B; Łukasik-Głębocka, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pålsson, P | 3 |
| Guldberg, J | 3 |
| Gustafsson, JM | 3 |
| Aiff, H | 3 |
| Luo, W | 1 |
| Sun, M | 1 |
| Wan, J | 1 |
| Zhang, Z | 1 |
| Huang, J | 1 |
| Zhang, J | 1 |
| Xiong, W | 1 |
| Xia, L | 1 |
| Xu, P | 1 |
| Miao, C | 1 |
| Zhang, X | 1 |
| Liu, M | 1 |
| Zhong, J | 1 |
| Hung, A | 1 |
| Marshall, J | 1 |
| Barnett, S | 1 |
| Falchuk, ZM | 1 |
| Sawhney, M | 1 |
| Leffler, DA | 1 |
| Łukasik-Głębocka, M | 1 |
| Sommerfeld, K | 1 |
| Teżyk, A | 1 |
| Zielińska-Psuja, B | 1 |
| Panieński, P | 1 |
| Żaba, C | 1 |
| Mainwaring, CJ | 1 |
| Wong, C | 1 |
| Lush, RJ | 1 |
| Smith, JG | 1 |
| Singer, CR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture[NCT00188227] | Phase 4 | 748 participants | Interventional | 2001-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for flumazenil and Blood Pressure, Low
| Article | Year |
|---|---|
Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial.
Topics: Ambulatory Surgical Procedures; Flumazenil; Humans; Hypotension; Pain; Propofol; Prospective Studies | 2023 |
4 other studies available for flumazenil and Blood Pressure, Low
| Article | Year |
|---|---|
Coma, Severe Hypotension, and Pinpoint Pupils After Olanzapine Intoxication in the Intensive Care Unit with Symptom Reversal After Administration of Flumazenil.
Topics: Aged; Benzodiazepines; Coma; Delirium; Flumazenil; Humans; Hypotension; Intensive Care Units; Male; | 2022 |
Coma, Severe Hypotension, and Pinpoint Pupils After Olanzapine Intoxication in the Intensive Care Unit with Symptom Reversal After Administration of Flumazenil.
Topics: Aged; Benzodiazepines; Coma; Delirium; Flumazenil; Humans; Hypotension; Intensive Care Units; Male; | 2022 |
Coma, Severe Hypotension, and Pinpoint Pupils After Olanzapine Intoxication in the Intensive Care Unit with Symptom Reversal After Administration of Flumazenil.
Topics: Aged; Benzodiazepines; Coma; Delirium; Flumazenil; Humans; Hypotension; Intensive Care Units; Male; | 2022 |
Coma, Severe Hypotension, and Pinpoint Pupils After Olanzapine Intoxication in the Intensive Care Unit with Symptom Reversal After Administration of Flumazenil.
Topics: Aged; Benzodiazepines; Coma; Delirium; Flumazenil; Humans; Hypotension; Intensive Care Units; Male; | 2022 |
Risk Factors and Outcomes of Reversal Agent Use in Moderate Sedation During Endoscopy and Colonoscopy.
Topics: Age Factors; Anti-Arrhythmia Agents; Antidotes; Atropine; Body Mass Index; Bradycardia; Case-Control | 2016 |
Flubromazolam--A new life-threatening designer benzodiazepine.
Topics: Adult; Antidotes; Benzodiazepines; Coma; Combined Modality Therapy; Designer Drugs; Drug Overdose; F | 2016 |
The role of midazolam-induced sedation in bone marrow aspiration/trephine biopsies.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Antidotes; Awareness; Bone Marrow; Conscious Sedation; | 1996 |